Organic compositions to treat HSF1-related diseases

Details for Australian Patent Application No. 2010332881 (hide)

Owner Novartis AG

Inventors Hinkle, Gregory; Kuchimanchi, Satyanarayana; Milstein, Stuart; Warmuth, Markus; Zhou, Wenlai; Zhu, Ping; Zimmermann, Tracy S.

Agent Davies Collison Cave

Pub. Number AU-A-2010332881

PCT Pub. Number WO2011/073326

Priority 61/288,137 18.12.09 US

Filing date 16 December 2010

Wipo publication date 23 June 2011

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/073326 Priority application(s): WO2011/073326

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332884-Granules for pharmaceutical preparations, methods and apparatus for their production

2010332880-Polyurethane composite system having high compressive strength and rigidity